84 related articles for article (PubMed ID: 15504417)
1. Oncogenic mutations reduce the stability of SRC kinase.
Falsone SF; Leptihn S; Osterauer A; Haslbeck M; Buchner J
J Mol Biol; 2004 Nov; 344(1):281-91. PubMed ID: 15504417
[TBL] [Abstract][Full Text] [Related]
2. Cysteine residues in the C-terminal lobe of Src: their role in the suppression of the Src kinase.
Oo ML; Senga T; Thant AA; Amin AR; Huang P; Mon NN; Hamaguchi M
Oncogene; 2003 Mar; 22(9):1411-7. PubMed ID: 12618767
[TBL] [Abstract][Full Text] [Related]
3. Most of the substrates of oncogenic viral tyrosine protein kinases can be phosphorylated by cellular tyrosine protein kinases in normal cells.
Kamps MP; Sefton BM
Oncogene Res; 1988 Sep; 3(2):105-15. PubMed ID: 2465525
[TBL] [Abstract][Full Text] [Related]
4. Purification of bovine thymus cytosolic C-terminal Src kinase (CSK) and demonstration of differential efficiencies of phosphorylation and inactivation of p56lyn and pp60c-src by CSK.
Cheng HC; Bjorge JD; Aebersold R; Fujita DJ; Wang JH
Biochemistry; 1996 Sep; 35(36):11874-87. PubMed ID: 8794770
[TBL] [Abstract][Full Text] [Related]
5. Cloning of a complementary DNA for a protein-tyrosine kinase that specifically phosphorylates a negative regulatory site of p60c-src.
Nada S; Okada M; MacAuley A; Cooper JA; Nakagawa H
Nature; 1991 May; 351(6321):69-72. PubMed ID: 1709258
[TBL] [Abstract][Full Text] [Related]
6. Regulation of the cellular src protein tyrosine kinase: interactions of the carboxyl terminal sequences residing between the kinase domain and tyrosine-527.
Cobb BS; Parsons JT
Oncogene; 1993 Nov; 8(11):2897-903. PubMed ID: 7692368
[TBL] [Abstract][Full Text] [Related]
7. Function, location, and regulation of the src protein-tyrosine kinase.
Varmus H; Hirai H; Morgan D; Kaplan J; Bishop JM
Princess Takamatsu Symp; 1989; 20():63-70. PubMed ID: 2484925
[TBL] [Abstract][Full Text] [Related]
8. Properties of tripartite chimeras between Src and Lck.
Kashishian A; MacAuley A; Cooper JA
Oncogene; 1990 Oct; 5(10):1463-70. PubMed ID: 2250908
[TBL] [Abstract][Full Text] [Related]
9. Activation of pp60c-src transforming potential by mutations altering the structure of an amino terminal domain containing residues 90-95.
Potts WM; Reynolds AB; Lansing TJ; Parsons JT
Oncogene Res; 1988; 3(4):343-55. PubMed ID: 2465527
[TBL] [Abstract][Full Text] [Related]
10. Src protein-tyrosine kinase structure and regulation.
Roskoski R
Biochem Biophys Res Commun; 2004 Nov; 324(4):1155-64. PubMed ID: 15504335
[TBL] [Abstract][Full Text] [Related]
11. v-Rel and c-Rel are differentially affected by mutations at a consensus protein kinase recognition sequence.
Mosialos G; Gilmore TD
Oncogene; 1993 Mar; 8(3):721-30. PubMed ID: 8437855
[TBL] [Abstract][Full Text] [Related]
12. Clustered cysteine residues in the kinase domain of v-Src: critical role for protein stability, cell transformation and sensitivity to herbimycin A.
Senga T; Miyazaki K; Machida K; Iwata H; Matsuda S; Nakashima I; Hamaguchi M
Oncogene; 2000 Jan; 19(2):273-9. PubMed ID: 10645006
[TBL] [Abstract][Full Text] [Related]
13. The regulatory region of Prague C v-Src inhibits the activity of the Schmidt-Ruppin A v-Src kinase domain.
Brábek J; Mojzita D; Hamplová L; Folk P
Folia Biol (Praha); 2002; 48(1):28-33. PubMed ID: 11871857
[TBL] [Abstract][Full Text] [Related]
14. Activation of the Src-family tyrosine kinase Hck by SH3 domain displacement.
Moarefi I; LaFevre-Bernt M; Sicheri F; Huse M; Lee CH; Kuriyan J; Miller WT
Nature; 1997 Feb; 385(6617):650-3. PubMed ID: 9024665
[TBL] [Abstract][Full Text] [Related]
15. Structure of the regulatory domains of the Src-family tyrosine kinase Lck.
Eck MJ; Atwell SK; Shoelson SE; Harrison SC
Nature; 1994 Apr; 368(6473):764-9. PubMed ID: 7512222
[TBL] [Abstract][Full Text] [Related]
16. Influence of acidic residues on substrate specificity of oncogene products pp60v-src and p56lck in vitro.
Tinker DA; Cartron JL; McMurray JS; Levin VA
Anticancer Res; 1992; 12(1):123-7. PubMed ID: 1567157
[TBL] [Abstract][Full Text] [Related]
17. Structural basis of SH2 domain mutations in X-linked agammaglobulinemia.
Vihinen M; Nilsson L; Smith CI
Biochem Biophys Res Commun; 1994 Dec; 205(2):1270-7. PubMed ID: 7528500
[TBL] [Abstract][Full Text] [Related]
18. Electrostatics and the membrane association of Src: theory and experiment.
Murray D; Hermida-Matsumoto L; Buser CA; Tsang J; Sigal CT; Ben-Tal N; Honig B; Resh MD; McLaughlin S
Biochemistry; 1998 Feb; 37(8):2145-59. PubMed ID: 9485361
[TBL] [Abstract][Full Text] [Related]
19. The activation loop in Lck regulates oncogenic potential by inhibiting basal kinase activity and restricting substrate specificity.
Laham LE; Mukhopadhyay N; Roberts TM
Oncogene; 2000 Aug; 19(35):3961-70. PubMed ID: 10962552
[TBL] [Abstract][Full Text] [Related]
20. Multiple phosphorylation of chicken protein tyrosine phosphatase 1 and human protein tyrosine phosphatase 1B by casein kinase II and p60c-src in vitro.
Jung EJ; Kang YS; Kim CW
Biochem Biophys Res Commun; 1998 May; 246(1):238-42. PubMed ID: 9600099
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
